Indication
Elmiron is indicated for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition.
Loading your page…
Loading your page…
Cystitis, Interstitial
Marketing Authorisation Holder: bene-Arzneimittel GmbH
EMA Authorisation: 02/06/2017
INN: pentosan polysulfate sodium
AI Drug & Interaction Analysis
Free account required
Ask Osler about Elmiron: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.